Chinese medicine stocks performed well 11 Chinese medicine stocks rose more than 50% in the year

Since this year, traditional Chinese medicine stocks have performed well Among the 55 tradable traditional Chinese medicine stocks, 53 stocks rose in the year, accounting for 96.36%, of which 11 stocks rose by more than 50%, Xiangxue Pharmaceutical (114.28%), foci Pharmaceutical (86.88%), zoelli Pharmaceutical (82.59%) and other stocks rose by more than 80% It is reported that Wang Lian, director of the Information Office of the State Administration of traditional Chinese medicine, recently said that up to now, China has issued 27 national standards of traditional Chinese medicine and more than 470 industrial and organizational standards The construction of the standard system of traditional Chinese medicine has begun to take shape The general principles for the preparation of clinical diagnosis and treatment guidelines of traditional Chinese medicine and the general principles for the preparation of standards for the industry of traditional Chinese medicine have entered the stage of review In particular, the draft of the standard system of traditional Chinese medicine has been completed Affected by the news, although the Shanghai stock index fell sharply yesterday, there were still a number of Chinese medicine stocks, such as Guizhou bailing (5.62%), Furui (2.23%), Lingrui Pharmaceutical (1.92%) and so on Since this year, traditional Chinese medicine stocks have performed well Among the 55 tradable traditional Chinese medicine stocks, 53 stocks rose in the year, accounting for 96.36%, of which 11 stocks rose by more than 50%, Xiangxue Pharmaceutical (114.28%), foci Pharmaceutical (86.88%), and zoli Pharmaceutical (82.59%) rose by more than 80% From the basic point of view, the latest data shows that from January to October, the income of Chinese Herbal Pieces increased by 27.9% year on year, and the profit increased by 26.5% year on year; from October, the income of single month increased by 42.0% year on year, and the profit increased by 20.4% year on year From January to October, the income of Chinese patent medicine increased by 21.9%, and the profit increased by 20.6%; from October, the income increased by 10.8%, and the profit increased by 11.8% year on year, and the growth rate of single month was higher than that of last month Fall back In response, market participants pointed out that the rapid growth of Chinese Herbal Pieces in October reflected strong terminal demand The slower growth rate of Chinese patent medicine in October is due to the reduction of some dealers' stock taking into account the subsequent price adjustment expectations of Chinese patent medicine Subsequently, with the increasingly clear policy, the growth rate of Chinese patent medicine consumption is expected to pick up The data further shows that the sales revenue of Chinese patent medicine last year was 407 billion 900 million yuan, an increase of 21.37% compared with 2011 The sales revenue in the first three quarters of this year was 353 billion 600 million yuan, an increase of 23.44% compared with the same period last year In recent years, the growth rate of sales revenue of Chinese patent medicine has been higher than that of the whole pharmaceutical manufacturing industry Under the expectation of Chinese patent medicine price reduction, it is expected that the growth rate of revenue of Chinese patent medicine will slow down slightly next year, but it can still maintain the growth rate higher than the overall industry On November 21, the UK medicines and health products authority said that in order to further help people purchase and use safe herbal products, unregistered herbal products will be banned from sale from April 30, 2014 In response to the incident, analysts said that banning unregistered herbal products in the UK was at best an overhaul of the existing market It has little impact on the Chinese medicine sector The export of traditional Chinese medicine mainly faces southeast Asia, Japan and other regions The total import volume of Europe and America is very low, mainly to meet the needs of local Chinese In addition, from the perspective of export categories, most of them are low value-added raw materials or pieces of Chinese herbal medicines, with small profits, so the UK market ban has little impact on the Chinese herbal medicine sector Founder Securities said that the leading enterprises in the modernization of traditional Chinese medicine deserve attention Although the recognition of traditional Chinese medicine in the international market requires the cultural communication of traditional Chinese medicine to take the lead, the European and American market is not a wall of iron With modern research as a means, it can also open the door of the European and American market Strengthening international cooperation and trade of traditional Chinese medicine is one of the key tasks during the 12th Five Year Plan period At the national level, there is a desire to strengthen and expand the industry of traditional Chinese medicine 14 departments, including the Ministry of Commerce and the State Administration of traditional Chinese medicine, put forward several opinions on promoting the development of service trade of traditional Chinese medicine, and support qualified traditional Chinese medicine enterprises Leading enterprises are expected to go abroad The leader of Recommend Tianshili, Zhongxin pharmaceutical, Yiling pharmaceutical, Kangyuan pharmaceutical, Hansen pharmaceutical, Guizhou bailing Independent framework of TCM standard system has been formed At present, 27 national standards of TCM have been issued, and more than 470 standards of industry and industry organizations have been issued A relatively independent and complete framework of TCM standard system has been formed, and a standardized management system and operation mechanism of TCM guided by the government, participated in by the industry, planned as a whole, and assigned responsibilities have been preliminarily established The draft table of TCM standard system has been completed Wang Lian, director of the office of the State Administration of traditional Chinese medicine and spokesman, said that in recent years, the State Administration of traditional Chinese medicine has issued and formulated a series of system construction documents, including the outline of the medium and long term development plan for the standardization of traditional Chinese medicine, the guiding opinions on strengthening the standardization of traditional Chinese medicine, and the administrative measures for the formulation of standards of traditional Chinese medicine Among them, the outline of the medium and long term development plan for the standardization of traditional Chinese medicine (TCM) defines five fields, 13 columns and 36 key tasks of TCM standardization The State Administration of traditional Chinese medicine has also strengthened the construction of TCM standard system We have carried out the development of national standards in an orderly manner and steadily promoted the development of industry and industry organization standards We have focused on the research and development of diagnosis and treatment guidelines for common diseases in clinical departments of traditional Chinese medicine At present, we have issued diagnosis and treatment guidelines for nearly 500 kinds of clinical common diseases covering more than ten departments Organized and drafted the general principles for the preparation of clinical diagnosis and treatment guidelines of traditional Chinese medicine, and the general principles for the preparation of industry standards of traditional Chinese medicine At the same time, the construction of TCM standardization support system is also in progress While organizing and promoting the establishment of the National Technical Committee for standardization of TCM information, ethnic medicine and medicated diet, the Bureau strengthened the informatization construction of TCM standardization, launched the construction of TCM standard website, and issued the online management system of TCM standard application evaluation project And support the construction of local TCM standardization organizations and the development of TCM standardization.